Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Clozapine × Lymphoid × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1 Classical hematology 1 CNS 1

Conditions

Lymphoma 1 Leukemia 1

Interventions

Rituximab 23 Surveys and Questionnaires 21 Gene Expression Profiling 12 Blood Specimen Collection 12 Polymerase Chain Reaction 11 Flow Cytometry 11 Amplified Fragment Length Polymorphism Analysis 10 Observation 9 Microarray Analysis 9 Lenalidomide 9 Watchful Waiting 8 Interviews as Topic 8 obinutuzumab 7 ibrutinib 7 Immunohistochemistry 7 Cytogenetic Analysis 7 Therapeutics 6 Magnetic Resonance Spectroscopy 6 Immunologic Techniques 5 Drug Therapy 5 Data Collection 5 tisagenlecleucel 4 Vincristine 4 Psychiatric Rehabilitation 4 Prednisone 4 Inotuzumab Ozogamicin 4 In Situ Hybridization, Fluorescence 4 Gene Rearrangement 4 Daunorubicin 4 Cyclophosphamide 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04074213 2019-08-30

CLOZARIX

University Hospital, Caen

1,000,000 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡